Together, they are furthering NuView Life Science’s mission: to change the way many types of cancer are diagnosed and treated using precision medicine technology. Diagnosing and treating cancer with a targeted, specific approach to the disease will help to increase positive patient outcomes while also driving down costs incurred by patients, healthcare providers, and third-party insurance payers.
Meet Our Management Team
Mr. Brock is a cum laude graduate of Harvard College (BA) and has a master’s in business administration (MBA) from The Harvard Business School.
His career of over 35 years in financial services began with investment banking at Merrill Lynch and subsequently led to executive positions at First Boston and Goldman Sachs. In addition to investment banking, Mr. Brock held senior positions in the fixed income capital markets department and was the global head of the medium-term note product area. While holding these positions, Mr. Brock had extensive interaction with Fortune 500 companies and major corporate and sovereign entities in Europe and Asia. He also headed a fixed income derivative desk at Salomon Brothers.
Mr. Brock has also been the president of an internet company focused on the middle market merger and acquisitions business and founded a leverage buyout firm which successfully invested in a portfolio of middle market industrial companies. He also served as the President of a financial company focused on advising and providing growth capital for wealth managers. These managers had more than $2 billion in Assets Under Management.
Over his career he has transacted billions of dollars of transactions for hundreds of companies domestically and internationally.
Mr. Brock has served as a director on several public company boards
Mr. Brock holds Series 7 and 63 licenses.